PL377052A1 - Krystaliczne fumarany 1-azabicyklo [2,2,2] oktylofuro [2,3-c] pirydynylokarboksyamidu oraz ich kompozycje i preparaty - Google Patents
Krystaliczne fumarany 1-azabicyklo [2,2,2] oktylofuro [2,3-c] pirydynylokarboksyamidu oraz ich kompozycje i preparatyInfo
- Publication number
- PL377052A1 PL377052A1 PL377052A PL37705203A PL377052A1 PL 377052 A1 PL377052 A1 PL 377052A1 PL 377052 A PL377052 A PL 377052A PL 37705203 A PL37705203 A PL 37705203A PL 377052 A1 PL377052 A1 PL 377052A1
- Authority
- PL
- Poland
- Prior art keywords
- azabicyclo
- oct
- preparations
- compositions
- fumarate salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43161902P | 2002-12-06 | 2002-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL377052A1 true PL377052A1 (pl) | 2006-01-23 |
Family
ID=32507764
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL377052A PL377052A1 (pl) | 2002-12-06 | 2003-12-01 | Krystaliczne fumarany 1-azabicyklo [2,2,2] oktylofuro [2,3-c] pirydynylokarboksyamidu oraz ich kompozycje i preparaty |
Country Status (22)
Country | Link |
---|---|
US (1) | US20050165047A1 (pl) |
EP (1) | EP1572700A1 (pl) |
JP (1) | JP2006510664A (pl) |
KR (1) | KR20050087826A (pl) |
CN (1) | CN1720248A (pl) |
AR (1) | AR042295A1 (pl) |
AU (1) | AU2003302911A1 (pl) |
BR (1) | BR0317019A (pl) |
CA (1) | CA2506529A1 (pl) |
CR (1) | CR7859A (pl) |
EA (1) | EA200500738A1 (pl) |
EC (1) | ECSP055834A (pl) |
HR (1) | HRP20050494A2 (pl) |
IS (1) | IS7844A (pl) |
MA (1) | MA27604A1 (pl) |
MX (1) | MXPA05005943A (pl) |
NO (1) | NO20052560L (pl) |
OA (1) | OA12968A (pl) |
PL (1) | PL377052A1 (pl) |
TW (1) | TW200427691A (pl) |
WO (1) | WO2004052894A1 (pl) |
ZA (1) | ZA200503988B (pl) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6670178B1 (en) | 1992-07-10 | 2003-12-30 | Transkaryotic Therapies, Inc. | In Vivo production and delivery of insulinotropin for gene therapy |
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
EP1603585A2 (en) | 2003-03-14 | 2005-12-14 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
DK2254598T3 (da) * | 2008-02-13 | 2013-07-29 | Targacept Inc | Kombination af alfa 7-nikotinagonister og antipsykotika |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
WO2011146511A1 (en) | 2010-05-17 | 2011-11-24 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3752373T2 (de) * | 1986-10-13 | 2004-03-25 | Asahi Kasei Kogyo K.K. | Pyridin-derivate |
AR036040A1 (es) * | 2001-06-12 | 2004-08-04 | Upjohn Co | Compuestos de heteroarilo multiciclicos sustituidos con quinuclidinas y composiciones farmaceuticas que los contienen |
-
2003
- 2003-12-01 MX MXPA05005943A patent/MXPA05005943A/es not_active Application Discontinuation
- 2003-12-01 EP EP03812627A patent/EP1572700A1/en not_active Withdrawn
- 2003-12-01 AU AU2003302911A patent/AU2003302911A1/en not_active Abandoned
- 2003-12-01 BR BR0317019-5A patent/BR0317019A/pt unknown
- 2003-12-01 PL PL377052A patent/PL377052A1/pl not_active Application Discontinuation
- 2003-12-01 CN CNA200380105166XA patent/CN1720248A/zh active Pending
- 2003-12-01 CA CA002506529A patent/CA2506529A1/en not_active Abandoned
- 2003-12-01 EA EA200500738A patent/EA200500738A1/ru unknown
- 2003-12-01 WO PCT/IB2003/005607 patent/WO2004052894A1/en not_active Application Discontinuation
- 2003-12-01 JP JP2004558940A patent/JP2006510664A/ja active Pending
- 2003-12-01 OA OA1200500173A patent/OA12968A/en unknown
- 2003-12-01 KR KR1020057010196A patent/KR20050087826A/ko not_active Application Discontinuation
- 2003-12-04 AR ARP030104471A patent/AR042295A1/es unknown
- 2003-12-05 TW TW092134360A patent/TW200427691A/zh unknown
-
2004
- 2004-10-08 US US10/962,071 patent/US20050165047A1/en not_active Abandoned
-
2005
- 2005-05-12 IS IS7844A patent/IS7844A/is unknown
- 2005-05-17 ZA ZA200503988A patent/ZA200503988B/en unknown
- 2005-05-26 NO NO20052560A patent/NO20052560L/no not_active Application Discontinuation
- 2005-06-02 HR HR20050494A patent/HRP20050494A2/hr not_active Application Discontinuation
- 2005-06-03 EC EC2005005834A patent/ECSP055834A/es unknown
- 2005-06-06 MA MA28315A patent/MA27604A1/fr unknown
- 2005-06-06 CR CR7859A patent/CR7859A/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
MXPA05005943A (es) | 2005-08-18 |
IS7844A (is) | 2005-05-12 |
CA2506529A1 (en) | 2004-06-24 |
US20050165047A1 (en) | 2005-07-28 |
ECSP055834A (es) | 2005-08-11 |
TW200427691A (en) | 2004-12-16 |
WO2004052894A1 (en) | 2004-06-24 |
AR042295A1 (es) | 2005-06-15 |
BR0317019A (pt) | 2005-10-25 |
JP2006510664A (ja) | 2006-03-30 |
HRP20050494A2 (en) | 2005-10-31 |
MA27604A1 (fr) | 2005-11-01 |
NO20052560D0 (no) | 2005-05-26 |
EP1572700A1 (en) | 2005-09-14 |
OA12968A (en) | 2006-10-13 |
AU2003302911A1 (en) | 2004-06-30 |
ZA200503988B (en) | 2006-09-27 |
KR20050087826A (ko) | 2005-08-31 |
NO20052560L (no) | 2005-08-17 |
CN1720248A (zh) | 2006-01-11 |
EA200500738A1 (ru) | 2005-12-29 |
CR7859A (es) | 2005-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP1100350A2 (en) | Maleate addition salts of hydropyridine derivates | |
AU2003233010A8 (en) | Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof | |
AU2002321878A1 (en) | Pyridinone and pyridazinone derivatives as gonadotropin-releasing hormone receptor antagonists | |
WO2000055125A3 (en) | N-cyanomethyl amides as protease inhibitors | |
PL392790A1 (pl) | Związki pirazolo [3, 4-b] pirydynowe i ich zastosowanie jako inhibitorów fosfodiesterazy | |
AU2001277741A1 (en) | 2-aminopyridine compounds and use thereof as drugs | |
HUP0400333A3 (en) | Crystalline anticholinergic, method for its production, and use thereof in the production of pharmaceutical composition | |
MXPA03006260A (es) | Derivados de amina sustituidos y metodos de uso. | |
AU2002319249A1 (en) | Herbicidal substituted pyridines, method for producing the same and their use as herbicidal agents and plant growth regulators | |
AU2003231231A1 (en) | Pyridinyl amino pyrimidine derivatives useful for treating hyper-proliferative disorders | |
AU2003229772A1 (en) | Derivatives of 2-(1-benzyl-1h-pyrazolo (3, 4-b)pyridine-3yl) -5-(4-pyridinyl)-4-pyrimidine amine and the use thereof as guanylate cyclase stimulators | |
HK1067129A1 (en) | A process for the preparation of perindopril, its analgous compounds and salts thereof using 2,5-dioxo-oxazolidine intermediate compounds | |
IS7844A (is) | Kristallskennd fumarat sölt af 1-asabísýkló[2.2.2]okt setnu fúró[2,3-c]pýridínýl karboxamíði og samsetningar og framleiðsla þeirra | |
GC0000362A (en) | 5-Chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3']bipyridinyl in pure crystalline form and process for synthesis | |
ZA200210278B (en) | 3-azabicyclo(3.1.0)hexane derivatives useful in therapy. | |
EP1395562A4 (en) | 5-CHLORO-3- (4-METHANSULFONYL PHENYL) -6 - METHYLC2,3-] BIPYRIDINYL IN PURE CRYSTALLINE FORM AND SYNTHESIS METHOD | |
AU1054500A (en) | N-substituted (3,6-dihydro)-2h-1,2-oxazine derivatives, their preparation and their use as selective mglur1 antagonists | |
IL162524A0 (en) | Derivatives of (pyridin-3-yl)-1-azabicycloÄ3.2.1Ü octane, their preparation and their terapeutic application | |
AU2001233086A1 (en) | Ceramidase compositions and methods based thereon | |
AU2002368487A1 (en) | Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists | |
HUP0204111A3 (en) | Novel process for the preparation of alpha-(2,4-disulfophenyl)-n-tert-butylnitrone and pharmaceutically acceptable salts thereof | |
HK1052464A1 (zh) | 眼生長和煙碱拮抗劑 | |
HK1049485B (zh) | 二硫雜環庚烯並[6,5-b]吡啶、和相關組合物與製備方法和用途 | |
AU2002366092A1 (en) | 1h-pyrrolo(3,2-b)pyridine-3-carboxylic acid amides | |
AU2002311623A1 (en) | Process for the preparation of 1,4-dihydropyridines and novel 1,4-dihydropyridines useful as therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |